BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$45.82
+5.33%Next report
Analyst consensus
- Next report date
- Feb 3, 2027
- EPS estimate
- $0.79
- Revenue estimate
- $5.2B
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $0.73
- EPS estimate
- $0.73
- Revenue actual
- $5.1B
- Revenue estimate
- $5.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.7%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $50
- PT range
- $44 – $65
- Analysts
- 16
11 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $0.73 | $0.73 | Beat 0.14% | $5.1B |
| Jul 29, 2026 | $0.84 | $0.86 | Beat 2.87% | $5.4B |
| Apr 22, 2026 | $0.79 | $0.80 | Beat 1.52% | $5.2B |
| Feb 4, 2026 | $0.78 | $0.80 | Beat 2.43% | $5.3B |
| Oct 22, 2025 | $0.71 | $0.75 | Beat 5.04% | $5.1B |
| Jul 23, 2025 | $0.72 | $0.75 | Beat 3.45% | $5.1B |
| Apr 23, 2025 | $0.67 | $0.75 | Beat 11.44% | $4.7B |
| Feb 5, 2025 | $0.66 | $0.70 | Beat 6.54% | $4.6B |
| Oct 23, 2024 | $0.59 | $0.63 | Beat 7.14% | $4.2B |
| Jul 24, 2024 | $0.58 | $0.62 | Beat 6.35% | $4.1B |
| Jan 31, 2024 | $0.51 | $0.55 | Beat 7.84% | $3.7B |
| Oct 26, 2023 | $0.48 | $0.50 | Beat 4.17% | $3.5B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 3, 2027